Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium
Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods...
Saved in:
Published in | European heart journal Vol. 26; no. 19; pp. 2039 - 2045 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Oxford University Press
01.10.2005
Oxford Publishing Limited (England) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods and results In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7–120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2–14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0–7.9) vs. 2.2% (1.0–5.8), respectively, P=0.42] Conclusion Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences. |
---|---|
AbstractList | Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. Methods and results In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7–120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2–14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0–7.9) vs. 2.2% (1.0–5.8), respectively, P=0.42] Conclusion Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences. Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium.AIMSUnfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium.In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42]METHODS AND RESULTSIn order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42]Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences.CONCLUSIONIschaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences. Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear whether ongoing or recurrent ischaemia is an independent determinant for increased apoptosis in peri-infarct viable myocardium. In order to assess the link between infarct-related artery (IRA) occlusion, ischaemia, and apoptosis, 30 subjects dying 7-120 days after AMI (16 with IRA occlusion and 14 with patent IRA) and five control subjects were selected at autopsy. Cardiomyocytes were defined as apoptotic if co-expressing TUNEL and activated caspase-3. Expression of both hypoxia-inducible factor-1 and cyclo-oxygenase-2 was assessed in the peri-infarct myocardium and considered as tissue markers of ischaemia. Evidence of ischaemia was significantly more frequent in cases with IRA occlusion (53%) than in cases with patent IRA (15%) or control hearts (0%, P=0.026). The finding of IRA occlusion and markers of ischaemia identified cases with higher apoptotic rates (ARs) in the peri-infarct viable myocardium [12.2% (8.2-14.0), P<0.001 vs. others], whereas IRA occlusion without ischaemia was associated with lower AR, not significantly different from patent IRA [3.0% (1.0-7.9) vs. 2.2% (1.0-5.8), respectively, P=0.42] Ischaemia in the peri-infarct viable myocardium is present in over 50% of subjects dying late after AMI with IRA occlusion, and it is associated with increased apoptosis. Relief of ischaemia after AMI may prove of benefit in preventing apoptosis and its consequences. |
Author | Sinagra, Gianfranco Severino, Anna Baldi, Alfonso Liuzzo, Giovanna Scarpa, Susanna Bussani, Rossana Baldi, Feliciano Vasaturo, Fortunata Vetrovec, George W. Leone, Antonio Maria Biasucci, Luigi M. Crea, Filippo Santini, Daniele Silvestri, Furio Giorgio, Fabio De Petrolini, Alessandro Abbate, Antonio Biondi-Zoccai, Giuseppe G.L. |
Author_xml | – sequence: 1 givenname: Antonio surname: Abbate fullname: Abbate, Antonio organization: Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA – sequence: 2 givenname: Rossana surname: Bussani fullname: Bussani, Rossana organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy – sequence: 3 givenname: Giuseppe G.L. surname: Biondi-Zoccai fullname: Biondi-Zoccai, Giuseppe G.L. organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 4 givenname: Daniele surname: Santini fullname: Santini, Daniele organization: Section of Oncology, Campus Bio-Medico University, Rome, Italy – sequence: 5 givenname: Alessandro surname: Petrolini fullname: Petrolini, Alessandro organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 6 givenname: Fabio De surname: Giorgio fullname: Giorgio, Fabio De organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 7 givenname: Fortunata surname: Vasaturo fullname: Vasaturo, Fortunata organization: Department of Experimental Medicine and Pathology, Università ‘La Sapienza’, Rome, Italy – sequence: 8 givenname: Susanna surname: Scarpa fullname: Scarpa, Susanna organization: Department of Experimental Medicine and Pathology, Università ‘La Sapienza’, Rome, Italy – sequence: 9 givenname: Anna surname: Severino fullname: Severino, Anna organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 10 givenname: Giovanna surname: Liuzzo fullname: Liuzzo, Giovanna organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 11 givenname: Antonio Maria surname: Leone fullname: Leone, Antonio Maria organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 12 givenname: Feliciano surname: Baldi fullname: Baldi, Feliciano organization: Department of Biochemistry ‘F. Cedrangolo’, Pathologic Anatomy, Second University of Naples, Naples, Italy – sequence: 13 givenname: Gianfranco surname: Sinagra fullname: Sinagra, Gianfranco organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy – sequence: 14 givenname: Furio surname: Silvestri fullname: Silvestri, Furio organization: Institute of Pathological Anatomy and Department of Cardiology, University of Trieste, Trieste, Italy – sequence: 15 givenname: George W. surname: Vetrovec fullname: Vetrovec, George W. organization: Department of Medicine, Virginia Commonwealth University MCV Campus, Richmond, VA, USA – sequence: 16 givenname: Filippo surname: Crea fullname: Crea, Filippo organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 17 givenname: Luigi M. surname: Biasucci fullname: Biasucci, Luigi M. organization: Institute of Cardiology and Department of Forensic Medicine, Catholic University, Rome, Italy – sequence: 18 givenname: Alfonso surname: Baldi fullname: Baldi, Alfonso organization: Department of Biochemistry ‘F. Cedrangolo’, Pathologic Anatomy, Second University of Naples, Naples, Italy |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17143368$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16030061$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkkFv1DAQhS1URLcLd07IQoJTQ-04dpxjqYAWrYADoIqL5dgTrZckDraDWIkfj6ssrdQDnCyNvvfGM_NO0NHoR0DoKSWvKGnYGcxhCzqk3RlsXUWbB2hFeVkWjaj4EVoR2vBCCHl9jE5i3BFCpKDiETqmgjBCBF2h31djp4NJRYBeJ7A4u0HYY29MP0fnx1OcXIwz4EGH7xAi9h120Ww1DE6fYj1a7EYTQMcb8eSn5KOLuYbTFvAEwRVuaYF_Ot322WjvjQ7WzcNj9LDTfYQnh3eNvrx98_nisth8fHd1cb4pTCVoKqxpjTFVKZltpJAdZXVNWFnLtpEWjCGlkS3UllQtdKJilvC24twK3XSWso6t0cvFdwr-xwwxqSGPAH2vR_BzVELyhtVZuUbP74E7P4cx_02VlFdNyev_QrISNcvQswM0twNYNQWXF7hXfzefgRcHQEej-y7o0bh4x9W0YkzIzJGFM8HHGKC7Q4i6CYG6DYFaQpAl4p7EuKRTPmYK2vX_EhaL0MUEv24b5cOrPFPN1eX1N8XffxKvv34QasP-ANd2y4o |
CitedBy_id | crossref_primary_10_4155_fmc_09_66 crossref_primary_10_1016_j_jacc_2008_01_003 crossref_primary_10_1161_JAHA_119_012351 crossref_primary_10_1016_j_biopha_2018_03_010 crossref_primary_10_3892_ijmm_2018_3851 crossref_primary_10_1016_j_tetlet_2008_08_091 crossref_primary_10_1016_j_bbrep_2023_101463 crossref_primary_10_1016_j_mehy_2013_02_024 crossref_primary_10_1016_j_bmcl_2008_05_002 crossref_primary_10_1002_ccd_21468 crossref_primary_10_1016_j_ijcard_2015_06_008 crossref_primary_10_1371_journal_pone_0058567 crossref_primary_10_1016_j_ijcard_2005_11_025 crossref_primary_10_1097_FJC_0b013e3181a7b5b6 crossref_primary_10_1152_ajpheart_ajpheart_91438_2007 crossref_primary_10_1016_j_jacc_2008_04_025 crossref_primary_10_1016_j_ijcard_2006_08_077 crossref_primary_10_3389_fcvm_2022_1003282 crossref_primary_10_1016_j_amjcard_2018_12_019 crossref_primary_10_1007_s10557_008_6154_3 crossref_primary_10_1007_s00210_023_02904_9 crossref_primary_10_1016_j_heliyon_2021_e07561 crossref_primary_10_1056_NEJMe0708910 crossref_primary_10_1093_abbs_gmy118 crossref_primary_10_1113_expphysiol_2012_069831 crossref_primary_10_1097_FJC_0b013e3181c87e53 crossref_primary_10_1007_s10517_011_1219_x crossref_primary_10_1038_s41420_024_01938_z crossref_primary_10_1016_j_ahj_2010_09_025 crossref_primary_10_1155_2013_658480 crossref_primary_10_1161_CIRCRESAHA_115_308165 crossref_primary_10_1371_journal_pone_0053265 crossref_primary_10_1007_s00109_008_0362_y crossref_primary_10_1007_s10495_006_6306_5 crossref_primary_10_1161_JAHA_112_002360 crossref_primary_10_2217_ica_09_38 crossref_primary_10_1161_CIRCIMAGING_112_979633 crossref_primary_10_1093_eurheartj_ehq446 crossref_primary_10_1016_j_ijcard_2007_03_117 crossref_primary_10_1016_j_amjcard_2009_03_019 crossref_primary_10_1016_j_nucmedbio_2011_12_008 crossref_primary_10_1097_FJC_0b013e31814b91cb crossref_primary_10_1097_FJC_0b013e31804a5e50 crossref_primary_10_18632_oncotarget_22946 crossref_primary_10_1089_rej_2009_0941 crossref_primary_10_1016_j_amjcard_2009_12_039 crossref_primary_10_1021_jm8015014 crossref_primary_10_4103_jfsm_jfsm_25_24 crossref_primary_10_2217_fca_11_29 crossref_primary_10_3814_2009_979318 crossref_primary_10_1152_ajpheart_00144_2019 crossref_primary_10_1016_j_mcna_2007_03_005 crossref_primary_10_1016_j_amjcard_2006_08_025 crossref_primary_10_1128_JCM_05129_11 crossref_primary_10_1016_j_jacc_2007_11_062 crossref_primary_10_1002_clc_22356 crossref_primary_10_1002_jcp_25576 crossref_primary_10_1007_s10151_018_1893_z crossref_primary_10_1016_j_jacc_2024_05_043 crossref_primary_10_1161_CIRCULATIONAHA_107_740233 |
Cites_doi | 10.1016/S0033-0620(00)70009-0 10.1172/JCI17664 10.1056/NEJM199912233412601 10.1152/jappl.2000.88.4.1474 10.1172/JCI119656 10.1136/hrt.2003.010280 10.1016/j.jacc.2003.09.026 10.1016/S0002-9149(98)00899-6 10.1161/01.cir.0000089041.69175.9d 10.1006/jmcc.2001.1457 10.1006/jmcc.1996.0193 10.1161/01.CIR.98.2.100 10.1016/S0735-1097(01)01683-7 10.1016/S0735-1097(01)01769-7 10.1136/heart.89.10.1138 10.1016/S0735-1097(98)00041-2 10.1016/S0002-9149(01)01967-1 10.1016/j.jtcvs.2003.08.012 10.1002/jcp.10174 10.1172/JCI119452 10.1161/01.RES.0000012202.52809.40 10.1016/S0735-1097(02)02122-8 10.1084/jem.20030613 10.1053/euhj.2002.3344 10.1016/S0008-6363(02)00716-2 10.1056/NEJM200106073442303 10.1016/0735-1097(95)00089-M 10.1016/S0167-5273(01)00578-2 10.1161/01.CIR.0000133316.92316.81 10.1159/000074813 10.1038/86498 10.1136/jcp.56.9.672 10.1016/S0735-1097(02)02959-5 10.1006/jmcc.2001.1498 10.1161/01.CIR.0000030936.97158.C4 10.1073/pnas.97.18.10197 |
ContentType | Journal Article |
Copyright | 2005 INIST-CNRS Copyright Oxford University Press(England) Oct 2005 |
Copyright_xml | – notice: 2005 INIST-CNRS – notice: Copyright Oxford University Press(England) Oct 2005 |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 |
DOI | 10.1093/eurheartj/ehi419 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1522-9645 |
EndPage | 2045 |
ExternalDocumentID | 1193421861 1196567801 16030061 17143368 10_1093_eurheartj_ehi419 ark_67375_HXZ_5JP6BVN6_L |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K -E4 .2P .GJ .I3 .XZ .ZR 08P 0R~ 18M 1B1 1TH 29G 2WC 4.4 482 48X 53G 5GY 5RE 5VS 5WA 5WD 70D AABZA AACZT AAFWJ AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNGD ABNHQ ABNKS ABOCM ABPQP ABPTD ABQLI ABQNK ABSMQ ABVGC ABWST ABXVV ABZBJ ACFRR ACGFO ACGFS ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACYHN ACZBC ADBBV ADEYI ADEZT ADGHP ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHUL AEJOX AEKPW AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFQV AFFZL AFIYH AFOFC AFSHK AFXAL AFYAG AGINJ AGKEF AGKRT AGMDO AGORE AGQPQ AGQXC AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AI. AIAGR AIJHB AJBYB AJDVS AJEEA AJNCP ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APJGH APWMN AQDSO AQKUS ASPBG ATGXG ATTQO AVNTJ AVWKF AXUDD AZFZN BAWUL BAYMD BCGUY BCRHZ BEYMZ BHONS BSCLL BTRTY BVRKM BZKNY C1A C45 CAG CDBKE COF CS3 CZ4 DAKXR DIK DILTD D~K E3Z EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IHE IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M41 MBLQV MHKGH ML0 N4W N9A NGC NOMLY NOYVH NQ- NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OB3 OBFPC OCZFY ODMLO OGROG OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RPZ RUSNO RW1 RXO RZF SEL TCURE TEORI TJX TMA UHS VH1 W8F WOQ X7H YAYTL YKOAZ YXANX ZGI ZKX ~91 AAYXX CITATION IQODW 6.Y ABQTQ ABSAR ADJQC ADRIX AFXEN CGR CUY CVF ECM EIF M49 NPM 7QP K9. 7X8 |
ID | FETCH-LOGICAL-c461t-dcbccc4283d9868f137703278b98decc02c8be7d04bef643d05b455d6a9fd13f3 |
ISSN | 0195-668X |
IngestDate | Fri Jul 11 12:14:01 EDT 2025 Mon Jun 30 06:53:03 EDT 2025 Mon Jun 30 03:28:38 EDT 2025 Thu Feb 13 05:32:21 EST 2025 Mon Jul 21 09:11:13 EDT 2025 Tue Jul 01 01:09:17 EDT 2025 Thu Apr 24 23:06:11 EDT 2025 Tue Aug 05 16:50:12 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 19 |
Keywords | Myocardial infarction Cyclo-oxygenase-2 Ischaemia Remodelling Enzyme Biological marker Cardiovascular disease Myocardial disease Phlebology Hypoxia-inducible factor-1 Oxygenase Tissue Ischemia Heart disease Transcription factor HIF1 Oxidoreductases Circulatory system Artery occlusion Cardiology Apoptosis |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c461t-dcbccc4283d9868f137703278b98decc02c8be7d04bef643d05b455d6a9fd13f3 |
Notes | istex:1A331A8F7D903B46D6E42898BD5A975D7A6EA8F7 href:ehi419 ark:/67375/HXZ-5JP6BVN6-L local:ehi419 Corresponding author. Fax: +1 360 3231204. E-mail address: abbatea@yahoo.com ObjectType-Article-1 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://academic.oup.com/eurheartj/article-pdf/26/19/2039/5942309/ehi419.pdf |
PMID | 16030061 |
PQID | 215484673 |
PQPubID | 29905 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_68593764 proquest_journals_215492574 proquest_journals_215484673 pubmed_primary_16030061 pascalfrancis_primary_17143368 crossref_primary_10_1093_eurheartj_ehi419 crossref_citationtrail_10_1093_eurheartj_ehi419 istex_primary_ark_67375_HXZ_5JP6BVN6_L |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-10-01 |
PublicationDateYYYYMMDD | 2005-10-01 |
PublicationDate_xml | – month: 10 year: 2005 text: 2005-10-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: England |
PublicationTitle | European heart journal |
PublicationTitleAlternate | Eur Heart J |
PublicationYear | 2005 |
Publisher | Oxford University Press Oxford Publishing Limited (England) |
Publisher_xml | – name: Oxford University Press – name: Oxford Publishing Limited (England) |
References | key 20171012003013_EHI419C7 key 20171012003013_EHI419C6 key 20171012003013_EHI419C9 key 20171012003013_EHI419C8 key 20171012003013_EHI419C3 key 20171012003013_EHI419C2 key 20171012003013_EHI419C5 key 20171012003013_EHI419C4 key 20171012003013_EHI419C28 key 20171012003013_EHI419C29 key 20171012003013_EHI419C26 key 20171012003013_EHI419C27 key 20171012003013_EHI419C24 key 20171012003013_EHI419C25 key 20171012003013_EHI419C22 key 20171012003013_EHI419C23 key 20171012003013_EHI419C20 key 20171012003013_EHI419C21 key 20171012003013_EHI419C30 key 20171012003013_EHI419C19 key 20171012003013_EHI419C17 key 20171012003013_EHI419C39 key 20171012003013_EHI419C18 key 20171012003013_EHI419C15 key 20171012003013_EHI419C37 key 20171012003013_EHI419C16 key 20171012003013_EHI419C38 key 20171012003013_EHI419C1 key 20171012003013_EHI419C13 key 20171012003013_EHI419C35 key 20171012003013_EHI419C14 key 20171012003013_EHI419C36 key 20171012003013_EHI419C11 key 20171012003013_EHI419C33 key 20171012003013_EHI419C12 key 20171012003013_EHI419C34 key 20171012003013_EHI419C31 key 20171012003013_EHI419C10 key 20171012003013_EHI419C32 |
References_xml | – ident: key 20171012003013_EHI419C22 doi: 10.1016/S0033-0620(00)70009-0 – ident: key 20171012003013_EHI419C24 doi: 10.1172/JCI17664 – ident: key 20171012003013_EHI419C18 doi: 10.1056/NEJM199912233412601 – ident: key 20171012003013_EHI419C11 doi: 10.1152/jappl.2000.88.4.1474 – ident: key 20171012003013_EHI419C16 doi: 10.1172/JCI119656 – ident: key 20171012003013_EHI419C28 doi: 10.1136/hrt.2003.010280 – ident: key 20171012003013_EHI419C26 doi: 10.1016/j.jacc.2003.09.026 – ident: key 20171012003013_EHI419C17 doi: 10.1016/S0002-9149(98)00899-6 – ident: key 20171012003013_EHI419C32 doi: 10.1161/01.cir.0000089041.69175.9d – ident: key 20171012003013_EHI419C10 – ident: key 20171012003013_EHI419C31 doi: 10.1006/jmcc.2001.1457 – ident: key 20171012003013_EHI419C36 doi: 10.1006/jmcc.1996.0193 – ident: key 20171012003013_EHI419C29 doi: 10.1161/01.CIR.98.2.100 – ident: key 20171012003013_EHI419C5 doi: 10.1016/S0735-1097(01)01683-7 – ident: key 20171012003013_EHI419C35 doi: 10.1016/S0735-1097(01)01769-7 – ident: key 20171012003013_EHI419C21 doi: 10.1136/heart.89.10.1138 – ident: key 20171012003013_EHI419C4 doi: 10.1016/S0735-1097(98)00041-2 – ident: key 20171012003013_EHI419C19 doi: 10.1016/S0002-9149(01)01967-1 – ident: key 20171012003013_EHI419C25 doi: 10.1016/j.jtcvs.2003.08.012 – ident: key 20171012003013_EHI419C3 doi: 10.1002/jcp.10174 – ident: key 20171012003013_EHI419C15 doi: 10.1172/JCI119452 – ident: key 20171012003013_EHI419C12 doi: 10.1161/01.RES.0000012202.52809.40 – ident: key 20171012003013_EHI419C9 doi: 10.1016/S0735-1097(02)02122-8 – ident: key 20171012003013_EHI419C27 doi: 10.1084/jem.20030613 – ident: key 20171012003013_EHI419C34 doi: 10.1053/euhj.2002.3344 – ident: key 20171012003013_EHI419C1 – ident: key 20171012003013_EHI419C30 doi: 10.1016/S0008-6363(02)00716-2 – ident: key 20171012003013_EHI419C33 doi: 10.1056/NEJM200106073442303 – ident: key 20171012003013_EHI419C20 doi: 10.1016/0735-1097(95)00089-M – ident: key 20171012003013_EHI419C37 doi: 10.1016/S0167-5273(01)00578-2 – ident: key 20171012003013_EHI419C14 doi: 10.1161/01.CIR.0000133316.92316.81 – ident: key 20171012003013_EHI419C23 doi: 10.1159/000074813 – ident: key 20171012003013_EHI419C38 doi: 10.1038/86498 – ident: key 20171012003013_EHI419C7 doi: 10.1136/jcp.56.9.672 – ident: key 20171012003013_EHI419C39 – ident: key 20171012003013_EHI419C6 doi: 10.1016/S0735-1097(02)02959-5 – ident: key 20171012003013_EHI419C8 doi: 10.1006/jmcc.2001.1498 – ident: key 20171012003013_EHI419C2 doi: 10.1161/01.CIR.0000030936.97158.C4 – ident: key 20171012003013_EHI419C13 doi: 10.1073/pnas.97.18.10197 |
SSID | ssj0008616 |
Score | 2.0964115 |
Snippet | Aims Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently... Unfavourable cardiac remodelling often complicates acute myocardial infarction (AMI) as a result of increased cardiomyocyte apoptosis. It is currently unclear... |
SourceID | proquest pubmed pascalfrancis crossref istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2039 |
SubjectTerms | Actins - metabolism Aged Aged, 80 and over Apoptosis Apoptosis - physiology Autopsy Biological and medical sciences Biomarkers - metabolism Cardiology. Vascular system Case-Control Studies Caspase 3 Caspases - metabolism Coronary heart disease Coronary Stenosis - metabolism Coronary Stenosis - pathology Cyclo‐oxygenase‐2 Female Heart Humans Hypoxia‐inducible factor‐1 Immunohistochemistry In Situ Nick-End Labeling Ischaemia Male Medical sciences Myocardial infarction Myocardial Infarction - pathology Myocardial Ischemia - metabolism Myocardial Ischemia - pathology Myocarditis. Cardiomyopathies Myocytes, Cardiac - pathology Remodelling Ventricular Remodeling - physiology |
Title | Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium |
URI | https://api.istex.fr/ark:/67375/HXZ-5JP6BVN6-L/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/16030061 https://www.proquest.com/docview/215484673 https://www.proquest.com/docview/215492574 https://www.proquest.com/docview/68593764 |
Volume | 26 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKJiFeEN-UwfADQkJdaNokbvLYsk7t2ArSWjTxEiW2I4rapmpSxBD_Gf8cd7bnfmgbHy9RlA878v3sO1_ufkfIq6Th-WGQhg4TLnd8FkgnTRoMs0Cypsi4KxLMRj4dsN7IPz4PziuVX2tRS8syfct_XJlX8j9ShWsgV8yS_QfJ2kbhApyDfOEIEobjX8m4P8sAp6WjElLAclTxmRe1nPPJEr1gOH6lGtnaFMNwFppgtsBI-amOktXkS2g6FtjAPJ-XOXKUmPBH5EF2xrqb2rexyrOaXoD-A1wZEodttz6WyC5r69-PeOp02sOuYSuAZSS3boDR2Vl70NdB3kWRzKyaOOl-GKy_gWlF45X7oH1yqN46khPlmck3_BeBjYQrb8qLXHd5RoHDmCpAbNdsnWV_ic1ofQV2NTmS0ebItn-lptAsWnK5UKPyFc-_jH3T1AYt95a6tEGMqnS8x8JbZLcJexQsn3HYf2_NgJCpurv2880_cui3bnut6z43bKJdnN7fMUY3KWCaZrq-yvUbIGUIDe-Ru2YHQ9sajvdJRc4ekNunJkbjIfm5hUqqUUktKg-oxiQ1mKR5Ri0mDyggklpEUotIuEYBkXQdkVQjkq4Q-YiMjrrDdz3H1PhwuM8apSN4yjlH1j8RhSzMkADT9ZqtMI1CAcuL2-RhKlvC9VOZgfUs3CD1g0CwJMpEw8u8x2Rnls_kU0JFU7pcsFQIpFQKeSiiQCaudEXqy8hvVUn9cpRjbgjwsQ7LJNaBGF5s5RJruVTJG_vGXJO_3PDsayU4-yAMIQZNtoK4d_45Do4_ss6nAYtPqmR_Q7Krlg2eqmTvUtSxmaxF3ETXAhg13rV3I1C-fpW8tHdBT-DPv2Qm82URMyQ2bDF44olGz6pfBooezPpnf_qwPXJnNYGfk51ysZQvwCQv030F_d8GP-0e |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Infarct-related+artery+occlusion%2C+tissue+markers+of+ischaemia%2C+and+increased+apoptosis+in+the+peri-infarct+viable+myocardium&rft.jtitle=European+heart+journal&rft.au=ABBATE%2C+Antonio&rft.au=BUSSANI%2C+Rossana&rft.au=LEONE%2C+Antonio+Maria&rft.au=BALDI%2C+Feliciano&rft.date=2005-10-01&rft.pub=Oxford+University+Press&rft.issn=0195-668X&rft.volume=26&rft.issue=19&rft.spage=2039&rft.epage=2045&rft_id=info:doi/10.1093%2Feurheartj%2Fehi419&rft.externalDBID=n%2Fa&rft.externalDocID=17143368 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0195-668X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0195-668X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0195-668X&client=summon |